Company / Current Assets per Share
Viking Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$6.41
FY2025
5-year range
$2.13 / $9.06
FY2021-FY2025
Trend
-29.2%
vs FY2024
Sector context
#114 of 210
Health Care
What the data says
At $6.41, Viking Therapeutics, Inc.'s current assets per share ranks #114 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $1.05 in FY2017 to $9.06 in FY2024.
Based on SEC 10-K filings.
6.41 in FY2025 with a 5-year CAGR of +12.6%.
Improved from $4.69 to $6.41 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +44.3%
- 5-Year CAGR
- +12.6%
- 10-Year CAGR
- -
Sector benchmark
#114 of 210 in Health CareTop 54% of 210This company $6.41 Sector average $170.65
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 29.2% year-over-year.
- Ranks #114 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2024.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.41 | -29.2% |
| FY2024 | $9.06 | +93.1% |
| FY2023 | $4.69 | +119.8% |
| FY2022 | $2.13 | -25.8% |
| FY2021 | $2.88 | -18.7% |
| FY2020 | $3.54 | -10.5% |
| FY2019 | $3.95 | -53.2% |
| FY2018 | $8.44 | +703.9% |
| FY2017 | $1.05 | -27.3% |
| FY2016 | $1.44 | -43.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026